Phexxi Gel
Product Images NDC 69751-100

12 FDA label images from Evofem, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Phexxi (NDC 69751-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Evofem, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Phexxi 01)

Chemical Structure (Phexxi 01)
Chemical structure of lactic acid, one of the active ingredients in Phexxi vaginal gel. The structure shows the molecular arrangement of lactic acid, a key component of the medication. This illustration is part of the product's FDA drug labeling.*
FDA Label Image

Chemical Structure (Phexxi 02)

Chemical Structure (Phexxi 02)
Chemical structural formula of citric acid monohydrate, one of the active ingredients in Phexxi, a vaginal gel containing lactic acid, citric acid monohydrate, and potassium bitartrate.*
FDA Label Image

Chemical Structure (Phexxi 03)

Chemical Structure (Phexxi 03)
Chemical structure of potassium bitartrate, one of the active ingredients in Phexxi vaginal gel (lactic acid, L-, citric acid monohydrate, and potassium bitartrate). The structure shows the molecular arrangement including potassium ion and multiple hydroxyl and carboxyl groups.*
FDA Label Image

Figure A (Phexxi 04)

Figure A (Phexxi 04)
An instructional diagram of a vaginal gel applicator for Phexxi, showing labeled parts including the pink cap, pre-filled applicator with a grooved area, tip of the plunger rod, and the plunger rod itself. This visual aids in identifying each component of the applicator used for gel administration.*
FDA Label Image

Figure B (Phexxi 05)

Figure B (Phexxi 05)
An instructional illustration showing a hand holding three individually packaged sachets or applicators, likely related to the use or administration of the product Phexxi vaginal gel.*
FDA Label Image

Figure C (Phexxi 06)

Figure C (Phexxi 06)
An instructional illustration showing how to assemble a syringe-like applicator for vaginal gel administration. The sequence depicts removing the cap from the syringe, attaching a plunger, and preparing the device for use. This diagram is relevant for Phexxi vaginal gel application.*
FDA Label Image

Figure D (Phexxi 07)

Figure D (Phexxi 07)
An instructional illustration showing a hand holding a syringe-like applicator for vaginal gel, with the other hand positioned to remove the cap from the applicator tip. This image likely demonstrates preparation steps for administering Phexxi vaginal gel.*
FDA Label Image

Figure E (Phexxi 08)

Figure E (Phexxi 08)
An illustration showing a hand holding a vaginal gel applicator filled with gel, demonstrating how to hold the applicator for administration. The image relates to Phexxi vaginal gel by Evofem, Inc.*
FDA Label Image

Figure F (Phexxi 09)

Figure F (Phexxi 09)
An instructional black-and-white line drawing showing the insertion of a vaginal gel applicator. The illustration depicts a hand holding the applicator positioned for vaginal administration, highlighting the correct placement within the vaginal canal.*
FDA Label Image

Figure G (Phexxi 10)

Figure G (Phexxi 10)
Illustration showing the proper application of a vaginal gel using an applicator. The diagram depicts a hand holding the applicator and positioning it at the vaginal opening, indicating insertion direction with an arrow.*
FDA Label Image

Figure H (Phexxi 11)

Figure H (Phexxi 11)
An instructional illustration showing a hand holding and inserting a vaginal applicator, depicting the correct technique for administering gel into the vaginal canal.*
FDA Label Image

Principal Display Panel (12 Applicator Box)

Principal Display Panel (12 Applicator Box)
Phexxi vaginal gel packaging label, displaying the product name and active ingredients (lactic acid, citric acid, potassium bitartrate) with strengths of 1.8%, 1%, and 0.4%. The label includes dosage form as vaginal gel, storage instructions, and usage warnings. Manufactured by Evofem, Inc. The package also shows barcode, GTIN, and space for expiration and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.